Revision as of 02:38, 3 January 2025 editExpulldordiamania (talk | contribs)87 edits ←Created page with '{{chembox | Verifiedfields = | Watchedfields = | verifiedrevid = | ImageFile = Wwwwwwwwwww222.png | ImageFile2 = Wwadwawd222.png | ImageCaption = | IUPACName = (7E,9E,11E)-trideca-7,9,11-trienoic acid | Section1 = {{Chembox Identifiers | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 28288114 | ChEMBL2_Ref = | ChEMBL2 = | InChI = InChI=1S/C13H20O2/c1-2-3-4-5-6-7-8-9-10-11-12-13(14)15/h2-7H,8-12H2,1H3,...' |
Revision as of 02:43, 3 January 2025 edit undoExpulldordiamania (talk | contribs)87 editsNo edit summaryNext edit → |
|
'''Trideca-7,9,11-trienoic acid''', or '''SCHEMBL9682082''', is an ]. It is present in '']''. It has been shown to have an antianxiety effect in '']'', '']'', and '']''. It causes hypolocomotion in ''Mus musculus'' and ''Rattus norvegicus''. A 2mg/Kg dose of ] has a very similiar effect to 20mg/Kg of trideca-7,9,11-trienoic acid.<ref name="three">{{cite journal |last1=Shri |first1=Richa |last2=Bhutani |first2=K.K. |last3=Sharma |first3=Anupam |year=2010 |title=A new anxiolytic fatty acid from Aethusa cynapium |journal=Fitoterapia |volume=81 |issue=5 |pages=337–340 |doi=10.1016/j.fitote.2010.05.003}}</ref><ref>{{cite patent }}Compounds and compositions for treating CNS disorders, Kerry L. Spear, Douglas Burdi, WO2021138314A1, WIPO, 8.7.2021. (https://patents.google.com/patent/WO2021138314A1/en)</ref> |
|
'''Trideca-7,9,11-trienoic acid''', or '''SCHEMBL9682082''', is an ]. It is present in '']''. It has been shown to have an antianxiety effect in '']'', '']'', and '']''. It causes hypolocomotion in ''Mus musculus'' and ''Rattus norvegicus''. A 2mg/Kg dose of ] has a very similiar effect to 20mg/Kg of trideca-7,9,11-trienoic acid.<ref name="three">{{cite journal |last1=Shri |first1=Richa |last2=Bhutani |first2=K.K. |last3=Sharma |first3=Anupam |year=2010 |title=A new anxiolytic fatty acid from Aethusa cynapium |journal=Fitoterapia |volume=81 |issue=5 |pages=337–340 |doi=10.1016/j.fitote.2010.05.003}}</ref><ref>{{cite patent }}Compounds and compositions for treating CNS disorders, Kerry L. Spear, Douglas Burdi, WO2021138314A1, WIPO, 8.7.2021. (https://patents.google.com/patent/WO2021138314A1/en)</ref><ref>{{Cite web |title=(7E,9E,11E)-trideca-7,9,11-trienoic acid |publisher=National Library of Medicine |work=PubChem |date=2025-03-01 |url=https://pubchem.ncbi.nlm.nih.gov/compound/(7E-9E-11E)-trideca-7-9-11-trienoic-acid}}</ref> |